NASDAQ · LABORATORY APPARATUS & FURNITURE · SMALL CAP
Kewaunee Scientific Corp. KEQU
17 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in KEWAUNEE SCIENTIFIC CORP /DE/'s annual report to the U.S. Securities and Exchange Commission, filed 26 June 2026. Every sentence was checked against that document before publication.
Growth
USD 282.0M
Revenue, FY2025 · full 17-year series below
Revenue $M
Net income $M
FY2025 · Revenue 282.0 · Net income 9.6
Compound annual growth
+8.7%
+13.8%
+8.2%
+7.2%
+135.3%
+9.7%
+11.6%
+134.4%
+8.5%
+10.5%
−13.1%
−4.2%
3 yrs
5 yrs
10 yrs
15 yrs
Revenue compounded at +13.8% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
4 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2025 · Operating 5.9% · Net 3.7%
ROE
FY2025 · ROE 13.8%
Each USD of equity produced 14 cents of profit this year.
The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Operating income $B | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBITDA $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income tax $B | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Free cash flow $B | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 |
| EPS, diluted $ | 3.22 | 3.83 | 6.38 | 0.25 | −2.20 | −1.33 | −1.70 | 0.55 | 1.90 | 1.66 | 1.42 | 1.33 | 1.48 | 1.17 | 0.40 | 0.72 | 1.39 |
| Dividend / sh $ | · | · | · | · | · | · | 0.38 | 0.74 | 0.66 | 0.58 | 0.51 | 0.47 | 0.44 | 0.40 | 0.40 | · | · |
| Payout % | · | · | · | · | · | −0 | −22 | 133 | 34 | 35 | 36 | 35 | 29 | 34 | 100 | 56 | 27 |
| ROE % | 13.8 | 19.1 | 40.7 | 2.0 | −15.9 | −9.2 | −11.0 | 3.2 | 11.6 | 11.1 | 10.4 | 10.3 | 11.9 | 9.9 | 3.4 | 6.0 | 11.7 |
| Shares out B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 83 reconciliationsAUDITED
Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityLaboratory Apparatus & Furniture
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsApril 30
SEC categorysmaller reporting company
Data on record since2009